Applied DNA Earnings Calls

Q4 2024 Missed
-$0.554 (-73.08%)
Release date Feb 13, 2025
EPS estimate -$0.320
EPS actual -$0.554
EPS Surprise -73.08%
Revenue estimate 1.175M
Revenue actual 1.197M
Revenue Surprise 1.84%
Q3 2024 Beat
-$0.320 (3.03%)
Release date Dec 17, 2024
EPS estimate -$0.330
EPS actual -$0.320
EPS Surprise 3.03%
Revenue estimate 899K
Revenue actual 3.431M
Revenue Surprise 281.69%
Q2 2024 Beat
$0.470 (234.29%)
Release date Aug 08, 2024
EPS estimate -$0.350
EPS actual $0.470
EPS Surprise 234.29%
Revenue estimate 900K
Revenue actual 797.519K
Revenue Surprise -11.39%
Q1 2024 Missed
-$5.31 (-15.43%)
Release date May 10, 2024
EPS estimate -$4.60
EPS actual -$5.31
EPS Surprise -15.43%
Revenue estimate 950K
Revenue actual 929.631K
Revenue Surprise -2.14%

Last 4 Quarters for Applied DNA

Below you can see how APDN performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.

Q1 2024 Missed
Release date May 10, 2024
Fiscal end date Mar 31, 2024
Price on release $3.45
EPS estimate -$4.60
EPS actual -$5.31
EPS surprise -15.43%
Date Price
May 06, 2024 $3.63
May 07, 2024 $3.60
May 08, 2024 $3.74
May 09, 2024 $3.74
May 10, 2024 $3.45
May 13, 2024 $3.08
May 14, 2024 $3.22
May 15, 2024 $2.96
May 16, 2024 $2.75
4 days before -4.96%
4 days after -20.29%
On release day -10.72%
Change in period -24.24%
Q2 2024 Beat
Release date Aug 08, 2024
Fiscal end date Jun 30, 2024
Price on release $0.350
EPS estimate -$0.350
EPS actual $0.470
EPS surprise 234.29%
Date Price
Aug 02, 2024 $0.377
Aug 05, 2024 $0.376
Aug 06, 2024 $0.400
Aug 07, 2024 $0.376
Aug 08, 2024 $0.350
Aug 09, 2024 $0.360
Aug 12, 2024 $0.360
Aug 13, 2024 $0.354
Aug 14, 2024 $0.445
4 days before -7.06%
4 days after 27.26%
On release day 2.86%
Change in period 18.27%
Q3 2024 Beat
Release date Dec 17, 2024
Fiscal end date Sep 30, 2024
Price on release $0.230
EPS estimate -$0.330
EPS actual -$0.320
EPS surprise 3.03%
Date Price
Dec 11, 2024 $0.215
Dec 12, 2024 $0.223
Dec 13, 2024 $0.165
Dec 16, 2024 $0.185
Dec 17, 2024 $0.230
Dec 18, 2024 $0.233
Dec 19, 2024 $0.187
Dec 20, 2024 $0.177
Dec 23, 2024 $0.167
4 days before 6.98%
4 days after -27.57%
On release day 1.26%
Change in period -22.51%
Q4 2024 Missed
Release date Feb 13, 2025
Fiscal end date Dec 31, 2024
Price on release $0.174
EPS estimate -$0.320
EPS actual -$0.554
EPS surprise -73.08%
Date Price
Feb 07, 2025 $0.169
Feb 10, 2025 $0.170
Feb 11, 2025 $0.183
Feb 12, 2025 $0.190
Feb 13, 2025 $0.174
4 days before 3.26%
4 days after 0%
On release day 0%
Change in period 3.26%

Applied DNA Earnings History

Earnings Calendar

FAQ

When is the earnings report for APDN?
Applied DNA (APDN) has scheduled its earnings report for May 08, 2025 after the markets close.

What is the APDN price-to-earnings (P/E) ratio?
APDN P/E ratio as of Feb 13, 2025 (TTM) is -0.0496.

What is the APDN EPS forecast?
The forecasted EPS (Earnings Per Share) for Applied DNA (APDN) for the first fiscal quarter 2025 is $.

What are Applied DNA's retained earnings?
On its balance sheet, Applied DNA reported retained earnings of $1.20 million for the latest quarter ending Dec 31, 2024.

What Is an Earnings Report?
An earnings report is usually issued quarterly (Q1, Q2, Q3 & Q4) by public companies to report their performance. Earnings reports typically include net income, earnings per share, earnings from continuing operations, and net sales. Looking at the earnings report investors can start gauge the financial health of the company and make even better decisions whether to buy, sell, or stay in the company. Fundamental analysts and value investors will typically hunt for stocks that continue to show good financial ratios and use a decline as an exit point. One of the most anticipated numbers for analysis is earnings per share because it indicates how much the company earned for its shareholders. The report will also indicate a possible dividend.

Earnings Report Content
Earnings reports generally provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. These figures are typically measured against previous quarters/years. Furthermore, the earnings report usually includes a summary and analysis from the CEO or company spokesman, alongside a more general view of the financials and future forecast.

What To Know About Earnings Reports?
Announcement of earnings for a stock, particularly for well followed large-capitalization stocks, can move the market. Stock prices can fluctuate wildly on days when the quarterly earnings report is released. Despite good reports, stocks may very well fall if the investors were expecting more or they believe the next quarter will not be as good. Investors always try to be ahead of the market and future earnings/losses are often discounted into the current price of the stock. It is natural for stocks to start to move in either direction a few days before the release of an earnings report.
Click to get the best stock tips daily for free!
ABOUT APPLIED DNA SCIENCES INC
Applied DNA
Applied DNA Sciences, Inc. develops and markets DNA-based technology solutions for use in the nucleic acid-based in vitro diagnostics and preclinical nucleic-acid based drug development and manufacturing markets; and for supply chain security, anti-counterfeiting, and anti-theft technology purposes. The company's supply chain security and product authentication solutions include SigNature molecular tags that provide forensic power and protection ...
GOLDEN STAR
Ticker Change Signal Date
IBN
$29.02
0.448% Feb 11
HCP
$34.11
0.733% Feb 11
VRNT
$26.02
0.92% Feb 11
BSY
$46.63
0.172% Feb 11
LFUS
$234.72
5.50% Feb 10

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE